Your browser doesn't support javascript.
loading
How Glutamate Is Managed by the Blood-Brain Barrier.
Hawkins, Richard A; Viña, Juan R.
Afiliación
  • Hawkins RA; Department of Physiology and Biophysics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL 60088, USA. rah@postharvard.edu.
  • Viña JR; Department of Biochemistry and Molecular Biology, Faculty of Medicine and Odontology, Medical Research Institute-INCLIVA, University of Valencia, Valencia 46010, Spain.
Biology (Basel) ; 5(4)2016 Oct 08.
Article en En | MEDLINE | ID: mdl-27740595
A facilitative transport system exists on the blood-brain barrier (BBB) that has been tacitly assumed to be a path for glutamate entry to the brain. However, glutamate is a non-essential amino acid whose brain content is much greater than plasma, and studies in vivo show that glutamate does not enter the brain in appreciable quantities except in those small regions with fenestrated capillaries (circumventricular organs). The situation became understandable when luminal (blood facing) and abluminal (brain facing) membranes were isolated and studied separately. Facilitative transport of glutamate and glutamine exists only on the luminal membranes, whereas Na⁺-dependent transport systems for glutamate, glutamine, and some other amino acids are present only on the abluminal membrane. The Na⁺-dependent cotransporters of the abluminal membrane are in a position to actively transport amino acids from the extracellular fluid (ECF) into the endothelial cells of the BBB. These powerful secondary active transporters couple with the energy of the Na⁺-gradient to move glutamate and glutamine into endothelial cells, whereupon glutamate can exit to the blood on the luminal facilitative glutamate transporter. Glutamine may also exit the brain via separate facilitative transport system that exists on the luminal membranes, or glutamine can be hydrolyzed to glutamate within the BBB, thereby releasing ammonia that is freely diffusible. The γ-glutamyl cycle participates indirectly by producing oxoproline (pyroglutamate), which stimulates almost all secondary active transporters yet discovered in the abluminal membranes of the BBB.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biology (Basel) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biology (Basel) Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza